Burundi vs Mali: HIV/AIDS deaths averted by antiretroviral therapy
Burundi
4,624 deaths
in 2024
Mali
5,460 deaths
in 2024
Burundi rank
39th
Mali rank
36th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Burundi
- Mali
How they compare
Mali currently reports 5,460 deaths against 4,624 deaths in Burundi, a difference of 836 deaths.
That makes Mali's figure about 1.2 times Burundi's.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Mali ahead.
Burundi ranks 39th and Mali ranks 36th of 157 countries.
Across the 4 decades both report, Burundi averaged higher in 2 and Mali in 1.
Head to head by decade
| Decade | Burundi | Mali | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,207 deaths | 1,193 deaths | 14.34 deaths | Burundi |
| 2010s | 4,004 deaths | 3,647 deaths | 356.66 deaths | Burundi |
| 2020s | 4,704 deaths | 4,734 deaths | 29.66 deaths | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Burundi or Mali?
- Mali, at 5,460 deaths against 4,624 deaths in Burundi as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Burundi and Mali?
- 836 deaths, with Mali ahead.
- How many years of comparable data are there for Burundi and Mali?
- 35 years are reported by both, from 1990 to 2024.
- How do Burundi and Mali rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Burundi ranks 39th and Mali ranks 36th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.